LSA
IOVA icon

Leonteq Securities AG’s Iovance Biotherapeutics IOVA Stock Holding History

Leonteq Securities AG’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$624K Sell
150,000
-10,000
-6% -$38K 0.02% 357
2026
Q1 		$562K Sell
160,000
-35,000
-18% -$112K 0.02% 388
2025
Q4 		$532K Buy
195,000
+100,000
+105% +$231K 0.02% 445
2025
Q3 		$206K Hold
95,000
– – 0.01% 602
2025
Q2 		$163K Buy
+95,000
New +$236K 0.01% 608
2025
Q1 		– Sell
-29,000
Closed -$150K – 1287
2024
Q4 		$215K Sell
29,000
-11,000
-28% -$102K 0.01% 528
2024
Q3 		$376K Hold
40,000
– – 0.03% 369
2024
Q2 		$321K Buy
40,000
+9,800
+32% +$105K 0.02% 396
2024
Q1 		$448K Sell
30,200
-19,800
-40% -$230K 0.03% 332
2023
Q4 		$407K Buy
50,000
+8,587
+21% +$44.9K 0.02% 361
2023
Q3 		$188K Buy
41,413
+30,609
+283% +$200K 0.01% 537
2023
Q2 		$76.1K Buy
10,804
+8,473
+363% +$60.6K ﹤0.01% 743
2023
Q1 		$14.2K Sell
2,331
-14,233
-86% -$98.2K ﹤0.01% 970
2022
Q4 		$106K Buy
16,564
+8,542
+106% +$66.7K ﹤0.01% 663
2022
Q3 		$76.9K Sell
8,022
-1,601
-17% -$18.5K ﹤0.01% 701
2022
Q2 		$106K Sell
9,623
-261
-3% -$3.42K ﹤0.01% 673
2022
Q1 		$165K Sell
9,884
-480
-5% -$7.42K 0.01% 630
2021
Q4 		$198K Sell
10,364
-994
-9% -$21.9K 0.01% 627
2021
Q3 		$280K Sell
11,358
-2,724
-19% -$64.2K 0.01% 519
2021
Q2 		$366K Buy
14,082
+14,055
+52,056% +$365K 0.02% 452
2021
Q1 		$855 Sell
27
-6
-18% -$249 ﹤0.01% 963
2020
Q4 		$1.53K Buy
+33
New +$1.31K ﹤0.01% 948

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Leonteq Securities AG's IOVA Position: Q2 2026 in Review

Leonteq Securities AG reduced its Iovance Biotherapeutics (IOVA) stake by 6.3% in Q2 2026, selling an estimated $38K and leaving 150,000 shares worth $624K. The position accounts for 0.02% of the portfolio, ranked #357.

Leonteq Securities AG first reported a position in IOVA in Q4 2020 and has held it in 22 quarters since. 288 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Leonteq Securities AG held 150,000 shares of Iovance Biotherapeutics worth $624K as of Q2 2026.
  • Leonteq Securities AG sold 10,000 Iovance Biotherapeutics shares in Q2 2026, an estimated $38K.
  • Iovance Biotherapeutics made up 0.02% of Leonteq Securities AG's portfolio in Q2 2026, its #357 holding.
  • Leonteq Securities AG first reported a position in Iovance Biotherapeutics in Q4 2020 and has held it in 22 quarters since.
  • 288 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.